Goldman Sachs’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $536M | Buy |
|
|||||
|
2025
Q2 | $418M | Sell |
|
|||||
|
2025
Q1 | $531M | Buy |
|
|||||
|
2024
Q4 | $459M | Buy |
|
|||||
|
2024
Q3 | $640M | Sell |
|
|||||
|
2024
Q2 | $724M | Buy |
|
|||||
|
2024
Q1 | $367M | Buy |
|
|||||
|
2023
Q4 | $327M | Sell |
|
|||||
|
2023
Q3 | $324M | Sell |
|
|||||
|
2023
Q2 | $361M | Buy |
|
|||||
|
2023
Q1 | $358M | Sell |
|
|||||
|
2022
Q4 | $406M | Buy |
|
|||||
|
2022
Q3 | $298M | Buy |
|
|||||
|
2022
Q2 | $245M | Buy |
|
|||||
|
2022
Q1 | $264M | Buy |
|
|||||
|
2021
Q4 | $237M | Sell |
|
|||||
|
2021
Q3 | $274M | Buy |
|
|||||
|
2021
Q2 | $199M | Sell |
|
|||||
|
2021
Q1 | $172M | Buy |
|
|||||
|
2020
Q4 | $113M | Sell |
|
|||||
|
2020
Q3 | $301M | Buy |
|
|||||
|
2020
Q2 | $335M | Buy |
|
|||||
|
2020
Q1 | $253M | Sell |
|
|||||
|
2019
Q4 | $255M | Buy |
|
|||||
|
2019
Q3 | $123M | Sell |
|
|||||
|
2019
Q2 | $190M | Buy |
|
|||||
|
2019
Q1 | $247M | Buy |
|
|||||
|
2018
Q4 | $191M | Sell |
|
|||||
|
2018
Q3 | $222M | Buy |
|
|||||
|
2018
Q2 | $175M | Sell |
|
|||||
|
2018
Q1 | $225M | Buy |
|
|||||
|
2017
Q4 | $188M | Buy |
|
|||||
|
2017
Q3 | $173M | Buy |
|
|||||
|
2017
Q2 | $183M | Buy |
|
|||||
|
2017
Q1 | $129M | Buy |
|
|||||
|
2016
Q4 | $120M | Sell |
|
|||||
|
2016
Q3 | $366M | Sell |
|
|||||
|
2016
Q2 | $319M | Buy |
|
|||||
|
2016
Q1 | $268M | Sell |
|
|||||
|
2015
Q4 | $454M | Buy |
|
|||||
|
2015
Q3 | $178M | Buy |
|
|||||
|
2015
Q2 | $180M | Buy |
|
|||||
|
2015
Q1 | $154M | Buy |
|
|||||
|
2014
Q4 | $90.5M | Sell |
|
|||||
|
2014
Q3 | $134M | Sell |
|
|||||
|
2014
Q2 | $328M | Buy |
|
|||||
|
2014
Q1 | $318M | Sell |
|
|||||
|
2013
Q4 | $350M | Buy |
|
|||||
|
2013
Q3 | $396M | Buy |
|
|||||
|
2013
Q2 | $278M | Buy |
|